Skip to content. | Skip to navigation

Garvan Institute

Sections
 

Dr Alex Swarbrick

 

Senior Research Officer, Group Leader, Tumour Progression Group, Cancer Program, Garvan Institute of Medical Research

Email: a.swarbrick"at"garvan.org.au
Research Group: Tumour Progression

 
 

Alex joined Garvan In January 2007 after undertaking postdoctoral studies in the laboratory of Nobel Laureate J. Michael Bishop at University of California, San Francisco.

Using cutting edge genetics and cell biology in vitro and in vivo, his group investigates the genes driving breast cancer progression.
 
Awards
2007 Sydney University Medal for Excellence in Medical Research
2005 CJ Martin Fellowship from the NHMRC
2004 Murdoch Fellowship from the American Australian Association
2003 Moredzadeh Fellowship for cancer research
2002 St Vincents and Mater Health primary award for excellence in research
 
Publications

Search here for publications by A Swarbrick and Australia
 
 
 

Areas of Interest

breast cancer, microRNAs, metastasis
 

News

 

Targeting aggressive breast cancers by putting them to sleep

MEDIA RELEASE: 25 Mar 2008
Dr Alex Swarbrick, head of Garvan's Tumour Progression Research Group, has published findings that Id1, a gene produced by the most aggressive forms of breast cancer, can control breast cancer growth. He has shown that by 'switching off' the Id1 gene, it is possible to induce a state of 'senescence', or permanent sleep, within a tumour, preventing it from growing or spreading.
 
 

Personal tools